Effect of Duration and Follicle Diameter During Oocyte Pick up on Embryological Parameters

February 17, 2024 updated by: Elif Güler Ergin, Eurofertil IVF Health Center

Does Follicle Diameter and Total Duration Spent for Oocyte Pick up Has Any Effect on Embryological Parameters and Clinical Pregnancy Rates

Investigators aim to investigate if the time spent for smaller follicles worth to deal with. The difference between follicle groups are recorded for embryological parameters. Results will be analysed for yielding transfer embryo and pregnancy rates between groups.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

There are papers about follicle dimensions and volumes studying their effect on embryologic parameters. But most of these studies are far from practical approach and are not easily applicable, such as 3D volumetric measurement is not feasible for most of the clinics. Also one of the points important for us it to evaluate the duration of the procedure and the possible positive effect of shortening the duration for better results. Investigators plan to measure the follicles just before puncture and arrange two groups. Group 1,follicles with diameter of 17 mm and more, and group 2 follicles between14-17 mm. Maturation, fertilization, cleavage characteristics are recorded. The source of chosen transfer embryo and crio-preserved embryos per cycle is also point of interest.

Study Type

Observational

Enrollment (Actual)

291

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Bursa, Turkey, 16
        • Bursa Eurofertil IVF Center
      • Bursa, Turkey, 16
        • Eurofertil IVF center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 36 years (Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Couples attending to our clinic for IVF - ICSI without history of RIF and severe male factor

Description

Inclusion Criteria:

  • 20-40 year old women

Exclusion Criteria:

  • History of recurrent implantation failure (RIF)
  • Known chromosomal abnormality
  • Severe male factor and azospermia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
group 1
follicles with a diameter of 17 mm and more
Procedure: follicle diameter and duration of procedure
to investigate if smaller follicles thrive embryos as the bigger follicles
Other Names:
  • success rates
group 2
follicles with a diameter of 14 mm to 17 mm
Procedure: follicle diameter and duration of procedure
to investigate if smaller follicles thrive embryos as the bigger follicles
Other Names:
  • success rates

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
transfer embryo
Time Frame: 5 to 7 days
comparing groups as the source of transfer embryo
5 to 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
clinical pregnancy
Time Frame: 3 weeks
comparing groups as the source of implanted embryo
3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Eurofertil IVF Health Center

Investigators

  • Study Director: gercek aydin, Bursa Eurofertil IVF Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 19, 2022

Primary Completion (Actual)

February 17, 2024

Study Completion (Actual)

February 17, 2024

Study Registration Dates

First Submitted

December 17, 2022

First Submitted That Met QC Criteria

December 17, 2022

First Posted (Actual)

December 27, 2022

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 17, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Eurofertil-OPU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

It is not decided yet but probably be available upon request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Follicle Size

Clinical Trials on follicle diameter and duration of procedure

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe